387 related articles for article (PubMed ID: 15256476)
1. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1.
Bau DT; Fu YP; Chen ST; Cheng TC; Yu JC; Wu PE; Shen CY
Cancer Res; 2004 Jul; 64(14):5013-9. PubMed ID: 15256476
[TBL] [Abstract][Full Text] [Related]
2. DNA double-strand break repair capacity and risk of breast cancer.
Bau DT; Mau YC; Ding SL; Wu PE; Shen CY
Carcinogenesis; 2007 Aug; 28(8):1726-30. PubMed ID: 17494053
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
Fu YP; Yu JC; Cheng TC; Lou MA; Hsu GC; Wu CY; Chen ST; Wu HS; Wu PE; Shen CY
Cancer Res; 2003 May; 63(10):2440-6. PubMed ID: 12750264
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
Willems P; Claes K; Baeyens A; Vandersickel V; Werbrouck J; De Ruyck K; Poppe B; Van den Broecke R; Makar A; Marras E; Perletti G; Thierens H; Vral A
Genes Chromosomes Cancer; 2008 Feb; 47(2):137-48. PubMed ID: 18000863
[TBL] [Abstract][Full Text] [Related]
6. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.
Wang HC; Chou WC; Shieh SY; Shen CY
Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194
[TBL] [Abstract][Full Text] [Related]
7. Absence of major defects in non-homologous DNA end joining in human breast cancer cell lines.
Mérel P; Prieur A; Pfeiffer P; Delattre O
Oncogene; 2002 Aug; 21(36):5654-9. PubMed ID: 12165865
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility.
Ding SL; Yu JC; Chen ST; Hsu GC; Kuo SJ; Lin YH; Wu PE; Shen CY
Carcinogenesis; 2009 Jan; 30(1):43-9. PubMed ID: 18974064
[TBL] [Abstract][Full Text] [Related]
9. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts.
Zhong Q; Boyer TG; Chen PL; Lee WH
Cancer Res; 2002 Jul; 62(14):3966-70. PubMed ID: 12124328
[TBL] [Abstract][Full Text] [Related]
10. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
[TBL] [Abstract][Full Text] [Related]
11. A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining.
Baldeyron C; Jacquemin E; Smith J; Jacquemont C; De Oliveira I; Gad S; Feunteun J; Stoppa-Lyonnet D; Papadopoulo D
Oncogene; 2002 Feb; 21(9):1401-10. PubMed ID: 11857083
[TBL] [Abstract][Full Text] [Related]
12. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.
Zhuang J; Zhang J; Willers H; Wang H; Chung JH; van Gent DC; Hallahan DE; Powell SN; Xia F
Cancer Res; 2006 Feb; 66(3):1401-8. PubMed ID: 16452195
[TBL] [Abstract][Full Text] [Related]
13. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
[TBL] [Abstract][Full Text] [Related]
14. The role of the BRCA1 tumor suppressor in DNA double-strand break repair.
Zhang J; Powell SN
Mol Cancer Res; 2005 Oct; 3(10):531-9. PubMed ID: 16254187
[TBL] [Abstract][Full Text] [Related]
15. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
[TBL] [Abstract][Full Text] [Related]
16. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk.
Han J; Hankinson SE; Zhang SM; De Vivo I; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):520-4. PubMed ID: 15066914
[TBL] [Abstract][Full Text] [Related]
17. The role of BRCA1 in non-homologous end-joining.
Bau DT; Mau YC; Shen CY
Cancer Lett; 2006 Aug; 240(1):1-8. PubMed ID: 16171943
[TBL] [Abstract][Full Text] [Related]
18. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells.
Frankenberg-Schwager M; Becker M; Garg I; Pralle E; Wolf H; Frankenberg D
Radiat Res; 2008 Dec; 170(6):784-93. PubMed ID: 19138034
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.
Jakubowska A; Narod SA; Goldgar DE; Mierzejewski M; Masojć B; Nej K; Huzarska J; Byrski T; Górski B; Lubiński J
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):457-9. PubMed ID: 12750242
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland.
Jorgensen TJ; Visvanathan K; Ruczinski I; Thuita L; Hoffman S; Helzlsouer KJ
Breast Cancer Res Treat; 2007 Jan; 101(1):65-71. PubMed ID: 16823510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
